Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. HeartWare plunges on extended pause for MVAD trial
Investors have pared 30.0% from HeartWare International since the company said that it may not be able to resume a trial of its MVAD implantable heart pump next month, as was expected.
Framingham, Mass.-based HeartWare, which put a hold on enrollment in its CE Mark trial Sept. 9 due to controller manufacturing and software issues, said it began investigating reports of adverse events in certain trial subjects, but didn’t explain the nature of the events other than to say that they’re “typical of those seen in other clinical trials for ventricular assist devices.” Read more
2. Strong dollar a drag on Johnson & Johnson’s 3rd-quarter medical device sales
The strong dollar put a -7.3% hurt on Johnson & Johnson’s medical device sales during the 3rd quarter, the company said, reporting a -29.3% hit to the bottom line on an overall sales decline of -7.4% compared with Q3 2014.
Medical device sales were $6.09 billion during the quarter, off -7.3% despite U.S. revenue growth of 2.0% to $3.0 billion. International medical device sales were down -14.8% to $3.09 billion, which included a 14.9% headwind from exchange rates overseas, Johnson & Johnson said. The company gets nearly half of its sales from outside the U.S. Read more
1. Medtronic touts CoreValve TAVI real-world registry data
Medtronic said it released the 1st real-world registry study of its CoreValve transcatheter aortic valve implant, reporting outcomes in-line with its clinical trials of the device.
The medtech giant also released new data from 3 studies focusing on new patient populations with significant comorbidities. Data from all of the CoreValve studies was presented at the annual Transcatheter Cardiovascular Therapeutics conference in San Franscisco. Read more
The post MassDevice.com +3 | The top 3 medtech stories for October 13, 2015 appeared first on MassDevice.
from MassDevice http://ift.tt/1RFHjeF
Cap comentari:
Publica un comentari a l'entrada